Janus Henderson Group Plc - Dec 31, 2024 SCHEDULE 13G/A Report for LIGAND PHARMACEUTICALS INCORPORATED Common Stock (LGND)

Filing Manager: JANUS HENDERSON GROUP PLC
Reporting Manager: JANUS HENDERSON GROUP PLC
Security: LIGAND PHARMACEUTICALS INCORPORATED Common Stock
Symbol: LGND
Shares outstanding: 18.8M shares
Disclosed Ownership: 1.02M shares
Ownership: 5.4%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 12:36 PM
Date of event: Dec 31, 2024
Next filing: May 14, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JANUS HENDERSON GROUP PLC	5.4%	1.02M	0	1.02M	Kristin Mariani	Head of North America Compliance, CCO